In this study, we demonstrated that YY1 overexpression by pre-S2 mutant-induced MTOR activation could stimulate aerobic glycolysis through MYC to upregulate SLC2A1, proposing a novel oncogenic role of YY1 in HCC development. Here, MYC is linked to hepatocellular carcinoma.